Antiphospholipid syndrome and recurrent miscarriage: A systematic review and meta-analysis

Journal of Reproductive Immunology

Volumn 123, Issue , 2017, Pages 78-87

  Santos, Thaís da Silva ^a   Ieque, Andressa Lorena ^a   de Carvalho, Hayalla Corrêa ^a   Sell, Ana Maria ^a   Lonardoni, Maria Valdrinez Campana ^a   Demarchi, Izabel Galhardo ^a   de Lima Neto, Quirino Alves ^a   Teixeira, Jorge Juarez Vieira ^a  

^a State University Maringa   (Brazil)

Author keywords

Antiphospholipid antibody; Antiphospholipid syndrome; Habitual abortion; Pregnancy complications

Indexed keywords

AUTOANTIBODY; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHATIDYLSERINE ANTIBODY; PHOSPHOLIPID ANTIBODY; UNCLASSIFIED DRUG; PHOSPHATIDYLSERINE;

ANTIPHOSPHOLIPID SYNDROME; DISEASE ASSOCIATION; HUMAN; MEDLINE; PRIORITY JOURNAL; PUBLISHING; RECURRENT ABORTION; REVIEW; SPONTANEOUS ABORTION; SYSTEMATIC REVIEW; WEB OF SCIENCE; ADULT; FEMALE; IMMUNOLOGY; META ANALYSIS; PHYSIOLOGIC MONITORING; PREGNANCY; STANDARD; SYSTEMIC LUPUS ERYTHEMATOSUS;

ABORTION, HABITUAL; ADULT; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; FEMALE; HUMANS; LUPUS COAGULATION INHIBITOR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MONITORING, PHYSIOLOGIC; PHOSPHATIDYLSERINES; PREGNANCY; PUBLICATION BIAS; REFERENCE STANDARDS;

EID: 85030320333     PISSN: 01650378     EISSN: 18727603     Source Type: Journal    
DOI: 10.1016/j.jri.2017.09.007     Document Type: Review

References (70)

1. Aisina, R.B., Mukhametova, L.I., Ostriakova, E.V., Seredavkina, N.V., Patrushev, L.I., Patrusheva, N.L., Reshetniak, T.M., Gulin, D.A., Gershkovich, K.B., Nasonov, E.L., Varfolomeev, S.D., Polymorphism of the plasminogen activator inhibitor type 1 gene, plasminogen level and thrombosis in patients with antiphospholipid syndrome. Biomed Khim. 60 (2014), 72–93.
2. Alijotas-Reig, J., Ferrer-Oliveras, R., Rodrigo-Anoro, M.J., Farran-Codina, I., Cabero-Roura, L., Vilardell-Tarres, M., Anti-β 2-glycoprotein-I and anti-phosphatidylserine antibodies in women with spontaneous pregnancy loss. Fertil. Steril. 93 (2010), 2330–2336.
3. Alves, C., Veiga, S., Toralles, M.B.P., Lopes, A.C.V., Major histocompatibility complex: its role in the physiology of pregnancy and in the pathogenic mechanisms of obstetric complications. Rev. Bras. Saúde Matern. Infant. 7 (2007), 357–363.
4. American Society for Reproductive Medicine, Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil. Steril. 98 (2012), 1103–1111.
5. American Society for Reproductive Medicine, Fact Sheet. 2016 http://www.reproductivefacts.org/news-and-publications/patient-fact-sheets-and-booklets/fact-sheets-and-info-booklets/what-is-recurrent-pregnancy-loss-rpl (accessed 21.07.2017).
6. Begg, C.B., Mazumdar, M., Operating characteristics of a rank correlation test for publication bias. Biometrics 50 (1994), 1088–1101.
7. Bertolaccini, M.L., Atsumi, T., Koike, T., Hughes, G.R., Khamashta, M.A., Antiprothrombin antibodies detected in two different assay systems: preval. Clin. significance Syst. lupus erythematosus. Thromb. Haemost. 93 (2005), 289–297.
8. Branch, D.W., Porter, T.F., Rittenhouse, L., Caritis, S., Sibai, B., Hogg, B., Lindheimer, M.D., Klebanoff, M., MacPherson, C., VanDorsten, J.P., Landon, M., Paul, R., Miodovnik, M., Meis, P., Thurnau, G., Antiphospholipid antibodies in women at risk for preeclampsia. Am. J. Obstet. Gynecol. 184 (2001), 825–834.
9. Branch, D.W., Silver, R.M., Porter, T.F., Obstetric antiphospholipid syndrome: current uncertainties should guide our way. Lupus 19 (2010), 446–452.
10. Cecatti, J., Tintori, E.M., Yela, D.A., Queiroz, M.L.S., Anticardiolipin antibodies among pregnant women with fetal death. Rev. Bras. Ginecol. Obstet. 2 (2000), 101–106, 10.1590/S0100-72032000000200007.
11. Chen, L., Quan, S., Ou, X.H., Kong, L., Decreased endometrial vascularity in patients with antiphospholipid antibodies-associated recurrent miscarriage during midluteal phase. Fertil Steril. 98 (2012), 1495–1502, 10.1016/j.fertnstert.2012.08.006.
12. Cohn, D.M., Goddijn, M., Middeldorp, S., Korevaar, J.C., Dawood, F., Farquharson, R.G., Recurrent miscarriage and antiphospholipid antibodies: prognosis of subsequent pregnancy. J. Thromb. Haemost. 8 (2010), 2208–2213.
13. Diejomaoh, M.F.E., Recurrent spontaneous miscarriage is still a challenging diagnostic and therapeutic quagmire. Med. Princ. Pract. 24 (2015), 38–55.
14. Egger, M., Davey Smith, G., Schneider, M., Minder, C., Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997), 629–634.
15. Faden, D., Tincani, A., Tanzi, P., Spatola, L., Lojacono, A., Tarantini, M., Balestrieri, G., Anti-beta 2 glycoprotein I antibodies in a general obstetric population: preliminary results on the prevalence and correlation with pregnancy outcome. Anti-(2 glycoprotein I antibodies are associated with some obstetrical complications, mainly preeclampsi. Eur. J. Obstet. Gynecol. Reprod. Biol. 73 (1997), 37–42.
16. Favaloro, E.J., Silvestrini, R., Assessing the usefulness of anticardiolipin antibody assays: a cautious approach is suggested by high variation and limited consensus in multilaboratory testing. Am. J. Clin. Pathol. 118 (2002), 548–557.
17. Forastiero, R.R., Martinuzzo, M.E., Cerrato, G.S., Kordich, L.C., Carreras, L.O., Relationship of anti beta2-glycoprotein I and anti prothrombin antibodies to thrombosis and pregnancy loss in patients with antiphospholipid antibodies. Thromb. Haemost. 78 (1997), 1008–1014.
18. Galarza-Maldonado, C., Kourilovitch, M.R., Pérez-Fernández, O.M., Gaybor, M., Cordero, C., Cabrera, S., Soroka, N.F., Obstetric antiphospholipid syndrome. Autoimmun. Rev. 11 (2012), 288–295.
19. Galli, M., Luciani, D., Bertolini, G., Barbui, T., Anti-β2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. Blood 102 (2003), 2717–2723.
20. Galli, M., Luciani, D., Bertolini, G., Barbui, T., Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 101 (2003), 1827–1832.
21. Galli, M., Should we include anti-prothrombin antibodies in the screening for the antiphospholipid syndrome?. J. Autoimmun. 15 (2000), 101–105.
22. Gris, J.-C., Perneger, T.V., Quéré, I., Mercier, E., Fabbro-Peray, P., Lavigne-Lissalde, G., Hoffet, M., Déchaud, H., Boyer, J.-C., Ripart-Neveu, S., Antiphospholipid/antiprotein antibodies, hemostasis-related autoantibodies, and plasma homocysteine as risk factors for a first early pregnancy loss: a matched case-control study. Blood 102 (2003), 3504–3513.
23. Higgins, J.P.T., Thompson, S.G., Deeks, J.J., Altman, D.G., Measuring inconsistency in meta-analyses. BMJ 327 (2003), 557–560.
24. Hoxha, A., Ruffatti, A., Pittoni, M., Bontadi, A., Tonello, M., Salvan, E., Plebani, M., Punzi, L., The clinical significance of autoantibodies directed against prothrombin in primary antiphospholipid syndrome. Clin. Chim. Acta 413 (2012), 911–913.
25. Jaslow, C.R., Carney, J.L., Kutteh, W.H., Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy losses. Fertil. Steril. 93 (2010), 1234–1243.
26. Jennings, I., Greaves, M., Mackie, I.J., Kitchen, S., Woods, T.A.L., Preston, E.F., Neqas, U.K., Lupus anticoagulant testing: improvements in performance in a UK NEQAS proficiency testing exercise after dissemination of national guidelines on laboratory methods. Br. J. Haematol. 119 (2002), 364–369.
27. Karmochkine, M., Berard, M., Piette, J.C., Cacoub, P., Aillaud, M.F., Harlet, J.R., Godeau, P., Boffa, M.C., Antiphosphatidylethanolamine antibodies in systemic lupus erythematosus. Lupus 2 (1993), 157–160.
28. Kutteh, W.H., Hinote, C.D., Antiphospholipid antibody syndrome. Obstet. Gynecol. Clin. North Am. 41 (2014), 113–132.
29. Kwak-Kim, J., Agcaoili, M.S.L., Aleta, L., Liao, A., Ota, K., Dambaeva, S., Beaman, K., Kim, J.W., Gilman‐Sachs, A., Management of women with recurrent pregnancy losses and antiphospholipid antibody syndrome. Am. J. Reprod. Immunol. 69 (2013), 596–607.
30. Lee, R.M., Emlen, W., Scott, J.R., Branch, D.W., Silver, R.M., Anti-β 2-glycoprotein I antibodies in women with recurrent spontaneous abortion, unexplained fetal death, and antiphospholipid syndrome. Am. J. Obstet Gynecol. 181 (1999), 642–648.
31. Lee, R.M., Branch, D.W., Silver, R.M., Immunoglobulin A anti-β 2-glycoprotein antibodies in women who experience unexplained recurrent spontaneous abortion and unexplained fetal death. Am. J. Obstet. Gynecol. 185 (2001), 748–753.
32. Levine, J.S., Branch, D.W., Rauch, J., The antiphospholipid syndrome. N. Engl J. Med. 346 (2002), 752–763.
33. Lončar, D., Anticardiolipin antibodies in pathogenesis of infertility. Vojnosanit. Pregl. 67 (2010), 216–219.
34. Male, C., Foulon, D., Hoogendoorn, H., Vegh, P., Silverman, E., David, M., Mitchell, L., Predictive value of persistent versus transient antiphospholipid antibody subtypes for the risk of thrombotic events in pediatric patients with systemic lupus erythematosus. Blood 106 (2005), 4152–4158.
35. Marai, I., Carp, H., Shai, S., Shabo, R., Fishman, G., Shoenfeld, Y., Autoantibody panel screening in recurrent miscarriages. Am. J. Reprod. Immunol. 51 (2004), 235–240.
36. Meroni, P.L., Pathogenesis of the antiphospholipid syndrome: an additional example of the mosaic of autoimmunity. J. Autoimmun. 30 (2008), 99–103.
37. Miyakis, S., Lockshin, M.D., Atsumi, T., Branch, D.W., Brey, R.L., Cervera, R., Derksen, R., De Groot, P.G., Koike, T., Meroni, P.L., International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J. Thromb. Haemost. 4 (2006), 295–306.
38. Motak-pochrzęst, H., Malinowski, A., The occurrence of immunological disturbances in patients with recurrent miscarriage (RM) of unknown etiology. Neuroendocrinol Lett. 34 (2013), 701–707.
39. Nahass, G.T., Antiphospholipid antibodies and the antiphospholipid antibody syndrome. J. Am. Acad. Dermatol. 36 (1997), 149–171.
40. Nowak, I., Malinowski, A., Barcz, E., Wilczyński, J.R., Wagner, M., Majorczyk, E., Motak-Pochrzęst, H., Banasik, M., Kuśnierczyk, P., Possible role of HLA-G, LILRB1 and KIR2DL4 gene polymorphisms in spontaneous miscarriage. Arch. Immunol. Ther. Exp. 64 (2016), 505–514.
41. Obayashi, S., Ozaki, Y., Sugi, T., Kitaori, T., Katano, K., Suzuki, S., Sugiura-Ogasawara, M., Antiphosphatidylethanolamine antibodies might not be an independent risk factor for further miscarriage in patients suffering recurrent pregnancy loss. J. Reprod Immunol. 85 (2010), 186–192.
42. Opatrny, L., David, M., Kahn, S.R., Shrier, I., Rey, E., Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: a metaanalysis. J. Rheumatol. 33 (2006), 2214–2221.
43. Perches, P.G., Domingues, D.P., Gomes, A.L., Ribeiro, A.M., Pereira, F.M.T., Rassi, I.E., Souza, A.W.S., Evaluation of antiphospholipid antibodies testing for the diagnosis of antiphospholipid syndrome. Rev. Bras. Reumatol. 114 (2009), 553–558, 10.1590/S0482-50042009000300005.
44. Porter, T.F., Scott, J.R., Evidence-based care of recurrent miscarriage. Best Pract Res. Clin. Obstet. Gynaecol. 19 (2005), 85–101.
45. Practice Committee of the American Society for Reproductive Medicine, Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertil. Steril., 99, 2013, 63.
46. Rai, R.S., Clifford, K., Cohen, H., Regan, L., High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies. Hum. Reprod. 10 (1995), 3301–3304.
47. Reber, G., Schousboe, I., Tincani, A., Sanmarco, M., Kveder, T., de Moerloose, P., Boffa, M.-C., Arvieux, J., Inter-laboratory variability of anti-β2-glycoprotein I measurement a collaborative study in the frame of the european forum on antiphospholipid antibodies standardization group. Thromb Haemost. 88 (2002), 66–73.
48. Reber, G., Tincani, A., Sanmarco, M., De Moerloose, P., Boffa, M.C., Proposals for the measurement of anti-β2-glycoprotein I antibodies. Standardization Group of the European Forum on Antiphospholipid Antibodies. J. Thromb Haemost. 2 (2004), 1860–1862.
49. Roye-Green, K., Frederick, J., Wharfe, G., Choo- Kang, E., Dacosta, V., Fletcher, H., Smikle, M., Antiphospholipid and other autoantibodies in a cohort of habitual aborters and healthy multiparous women in Jamaica. Hum. Antibodies 20 (2011), 1–5.
50. Ruiz-Irastorza, G., Khamashta, M.A., The treatment of antiphospholipid syndrome: a harmonic contrast. Best Pract. Res. Clin. Rheumatol. 21 (2007), 1079–1092.
51. Sanmarco, M., Clinical significance of antiphosphatidylethanolamine antibodies in the so-called seronegative antiphospholipid syndrome. Autoimmun. Rev. 9 (2009), 90–92.
52. Sater, M.S., Finan, R.R., Abu-Hijleh, F.M., Abu-Hijleh, T.M., Almawi, W.Y., Anti-phosphatidylserine, anti-cardiolipin, anti-β2 glycoprotein i and anti-prothrombin antibodies in recurrent miscarriage at 8–12 gestational weeks. Eur. J Obstet. Gynecol. Reprod. Biol 163 (2012), 170–174.
53. Sebastiani, G.D., Galeazzi, M., Morozzi, G., Marcolonao, R., The immunogenetics of the antiphospholipid syndrome, anticardiolipin antibodies, and lupus anticoagulant. Seminars in Arthritis and Rheumatism 25 (1996), 414–420, 10.1016/S0049-0172(96)80006-0.
54. Shamseer, L., Moher, D., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., Stewart, L.A., Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ, 349, 2015, g7647.
55. Sherer, Y., Tartakover-Matalon, S., Blank, M., Matsuura, E., Shoenfeld, Y., Multiple autoantibodies associated with autoimmune reproductive failure. J. Assist. Reprod. Genet. 20 (2003), 53–57.
56. Singh, N.K., Gupta, A., Behera, D.R., Dash, D., Elevated plasminogen activator inhibitor type-1 (PAI-1) as contributing factor in pathogenesis of hypercoagulable state in antiphospholipid syndrome. Rheumatol. Int. 33 (2013), 2331–2336.
57. Stirrat, G.M., Recurrent miscarriage I: definition and epidemiology. Lancet 336 (1990), 673–675.
58. Subrt, I., Ulcova-Gallova, Z., Cerna, M., Hejnalova, M., Slovanova, J., Bibkova, K., Micanova, Z., Recurrent pregnancy loss, plasminogen activator inhibitor-1 (-675) 4G/5G polymorphism and antiphospholipid antibodies in czech women. Am. J. Reprod. Immunol. 70 (2013), 54–58.
59. Sugi, T., Matsubayashi, H., Inomo, A., Dan, L., Makino, T., Antiphosphatidylethanolamine antibodies in recurrent early pregnancy loss and mid-to-late pregnancy loss. J. Obstet. Gynaecol. Res. 30 (2004), 326–332.
60. Sugiura-Ogasawara, M., Ozaki, Y., Suzumori, N., Management of recurrent miscarriage. J. Obstet. Gynaecol. Res. 40 (2014), 1174–1179.
61. The American College of Obstetricians and Gynecologists, Practice bulletin No. 132: antiphospholipid syndrome. Obstet. Gynecol. 120 (2012), 1514–1521.
62. Tincani, A., Allegri, F., Sanmarco, M., Cinquini, M., Taglietti, M., Balestrieri, G., Koike, T., Ichikawa, K., Meroni, P., Boffa, M.C., Anticardiolipin antibody assay: a methodological analysis for a better consensus in routine determinations: a cooperative project of the European Antiphospholipid Forum. Thromb. Haemost. 86 (2001), 575–583.
63. Tincani, A., Allegri, F., Balestrieri, G., Reber, G., Sanmarco, M., Meroni, P., Boffa, M.C., Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies. Thromb. Res. 114 (2004), 553–558.
64. Tong, M., Viall, C.A., Chamley, L.W., Antiphospholipid antibodies and the placenta: a systematic review of their in vitro effects and modulation by treatment. Hum. Reprod. Update 21 (2014), 97–118.
65. Ulcova-Gallova, Z., Krauz, V., Novakova, P., Milichovska, L., Micanova, Z., Bibkova, K., Sucha, R., Turek, J., Balvin, M., Rokyta, Z., Anti-phospholipid antibodies against phosphatidylinositol, and phosphatidylserine are more significant in reproductive failure than antibodies against cardiolipin only. Am. J. Reprod. Immunol. 54 (2005), 112–117.
66. Van Den Boogaard, E., Cohn, D.M., Korevaar, J.C., Dawood, F., Vissenberg, R., Middeldorp, S., Goddijn, M., Farquharson, R.G., Number and sequence of preceding miscarriages and maternal age for the prediction of antiphospholipid syndrome in women with recurrent miscarriage. Fertil. Steril. 99 (2013), 188–192.
67. Wilson, W.A., Gharavi, A.E., Koike, T., Lockshin, M.D., Branch, D.W., Piette, J., Brey, R., Derksen, R., Harris, E.N., Hughes, G.R.V., Triplett, D.A., Khamashta, M.A., International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum. 42 (1999), 1309–1311.
68. Yamada, H., Atsumi, T., Kato, E.H., Shimada, S., Morikawa, M., Minakami, H., Prevalence of diverse antiphospholipid antibodies in women with recurrent spontaneous abortion. Fertil. Steril. 80 (2003), 1276–1278.
69. Yamada, H., Atsumi, T., Kobashi, G., Ota, C., Kato, E.H., Tsuruga, N., Ohta, K., Yasuda, S., Koike, T., Minakami, H., Antiphospholipid antibodies increase the risk of pregnancy-induced hypertension and adverse pregnancy outcomes. J. Reprod. Immunol. 79 (2009), 188–195.
70. Yodfat, O., Blank, M., Krause, I., Shoenfeld, Y., The pathogenic role of anti-phosphatidylserine antibodies: active immunization with the antibodies leads to the induction of antiphospholipid syndrome. Clin. Immunol. Immunopathol. 78 (1996), 14–20.